title: Everolimus for liver transplant recipients: is it ready for prime time?
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
authors.forename: Pratima
authors.initials: P
authors.lastname: Sharma
authors.affiliation: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
authors.forename: Pranab
authors.initials: P
authors.lastname: Barman
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D020123:Sirolimus / Q000031:analogs & derivatives*; D016559:Tacrolimus / Q000008:administration & dosage*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus